Follow
Stephen N Birrell MD PhD FRACS
Stephen N Birrell MD PhD FRACS
HAVAH Therapeutics
Verified email at havahtx.com - Homepage
Title
Cited by
Cited by
Year
Progesterone receptor modulates ERα action in breast cancer
H Mohammed, IA Russell, R Stark, OM Rueda, TE Hickey, GA Tarulli, ...
Nature 523 (7560), 313-317, 2015
6092015
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer
BIG 1-98 Collaborative Group
New England Journal of Medicine 361 (8), 766-776, 2009
5892009
Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial
J Cuzick, I Sestak, S Cawthorn, H Hamed, K Holli, A Howell, JF Forbes, ...
The lancet oncology 16 (1), 67-75, 2015
4282015
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical …
MM Regan, P Neven, A Giobbie-Hurder, A Goldhirsch, B Ejlertsen, ...
The lancet oncology 12 (12), 1101-1108, 2011
4192011
Androgen receptor inhibits estrogen receptor-α activity and is prognostic in breast cancer
AA Peters, G Buchanan, C Ricciardelli, T Bianco-Miotto, MM Centenera, ...
Cancer research 69 (15), 6131-6140, 2009
4052009
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International …
G Viale, A Giobbie-Hurder, MM Regan, AS Coates, MG Mastropasqua, ...
Journal of clinical oncology 26 (34), 5569, 2008
3712008
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
G Berclaz, S Li, KN Price, AS Coates, M Castiglione-Gertsch, ...
Annals of Oncology 15 (6), 875-884, 2004
3212004
Androgens induce divergent proliferative responses in human breast cancer cell lines
SN Birrell, JM Bentel, TE Hickey, C Ricciardelli, MA Weger, DJ Horsfall, ...
The Journal of steroid biochemistry and molecular biology 52 (5), 459-467, 1995
3031995
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII
A Wallgren, M Bonetti, RD Gelber, A Goldhirsch, M Castiglione-Gertsch, ...
Journal of Clinical Oncology 21 (7), 1205-1213, 2003
2962003
Breast and prostate cancer: more similar than different
GP Risbridger, ID Davis, SN Birrell, WD Tilley
Nature Reviews Cancer 10 (3), 205-212, 2010
2772010
Role of the androgen receptor in human breast cancer
SN Birrell, RE Hall, WD Tilley
Journal of mammary gland biology and neoplasia 3 (1), 95-103, 1998
1621998
Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells
JM Bentel, SN Birrell, MA Pickering, DJ Holds, DJ Horsfall, WD Tilley
Molecular and cellular endocrinology 154 (1-2), 11-20, 1999
1261999
Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer
SN Birrell, LM Butler, JM Harris, G Buchanan, WD Tilley
The FASEB Journal 21 (10), 2285-2293, 2007
1062007
MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression
RE Hall, SN Birrell, WD Tilley, RL Sutherland
European journal of cancer 30 (4), 484-490, 1994
1001994
Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer
RE Hall, JO Aspinall, DJ Horsfall, SN Birrell, JM Bentel, RL Sutherland, ...
British journal of cancer 74 (8), 1175-1180, 1996
971996
Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors
EJ Cops, T Bianco-Miotto, NL Moore, CL Clarke, SN Birrell, LM Butler, ...
The Journal of steroid biochemistry and molecular biology 110 (3-5), 236-243, 2008
942008
Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression.
SN Birrell, DM Roder, DJ Horsfall, JM Bentel, WD Tilley
Journal of clinical oncology 13 (7), 1572-1577, 1995
941995
Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast …
A Goldhirsch, AS Coates, M Colleoni, M Castiglione-Gertsch, RD Gelber
Journal of clinical oncology 16 (4), 1358-1362, 1998
911998
Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate
G Buchanan, SN Birrell, AA Peters, T Bianco-Miotto, K Ramsay, EJ Cops, ...
Cancer research 65 (18), 8487-8496, 2005
862005
Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for …
MM Regan, KN Price, A Giobbie-Hurder, B Thürlimann, RD Gelber
Breast cancer research 13 (3), 1-16, 2011
842011
The system can't perform the operation now. Try again later.
Articles 1–20